Shanghai, China

Bo Song

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 2019-2024

Loading Chart...
Loading Chart...
9 patents (USPTO):

Title: The Innovative Contributions of Inventor Bo Song

Introduction

Bo Song, an accomplished inventor based in Shanghai, China, has made significant strides in the field of biotechnology. With a total of 9 patents to his name, he has developed groundbreaking inventions that show promise in medical applications, particularly in cancer treatment.

Latest Patents

Among his notable patents are innovations such as an antibody against glypican-3 (GPC3), which offers a therapeutic angle for diseases associated with this protein. The invention includes a single-chain antibody and a humanized antibody, emphasizing targeted biologic therapies. Furthermore, he has developed a chimeric antigen receptor (CAR) targeting CLD18A2. This innovative CAR comprises a protein that specifically recognizes CLD18A2, enabling immune effector cells to be modified for treating aggressive tumors, including pancreatic and stomach cancer.

Career Highlights

Bo Song has significantly impacted the medical industry through his work at various companies. He has been associated with Crage Medical Co., Limited and Carsgen Therapeutics Co., Ltd., where his expertise in biotechnology and antibody development has been instrumental in advancements in cancer therapies.

Collaborations

Throughout his career, Bo has collaborated with talented professionals, including Huamao Wang and Xiumei Cai. These partnerships have facilitated the exchange of ideas and knowledge, contributing to the innovative solutions that Bo Song continues to develop.

Conclusion

Bo Song's contributions to the field of biotechnology and his impressive portfolio of patents underscore his role as an influential inventor. His advancements in antibody technology and targeted cancer therapies exemplify the potential of innovative research to transform medical practices and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…